supported by unrestricted educational grants from: baveno ... · baveno, italy - october 1 0/11,...
TRANSCRIPT
www.aristea.com/acscrossroads
BAVENO, ITALY - OCTOBER 10/11, 2014V INTERNATIONAL ACS CROSSROADS
PROGRAM
A. MENARINI • BAYER • BOSTON SCIENTIFICBRISTOL-MYERS SQUIBB • ORBUS • PFIZER • PRO.MED • SANITEX
Supported by unrestricted educational grants from:
14.30 Welcome and Introduction
SESSION IUPDATE ON ORAL ANTIPLATELET THERAPIESChairmen: G. De Luca, F. Piscione
15.30 Resistance to aspirin and ADP-antagonists: Mechanism, prevalence and clinical relevance - M. Cattaneo
15.40 Update on pharmacological gastroprotection:when and how - G. Belli
15.50 Switching from clopidogrel to new ADP antagonist: When and how - G. Parodi
16.00 ACCOAST Study: is an upstream strategy still necessary? - J.P. Collet
16.10 Ticagrelor and its pleiotropic effects - D. Ardissino
16.20 Optimal duration of DAPT - G. De Luca
16.30 MODERATED DISCUSSIONDiscussants: M. Ferlini, G. Galasso, A. Mafrici,
M. Napodano, U. Zeymer
SESSION II TRIPLE ORAL THERAPY IN ACS: WHAT HAS BEEN DONE AND WHAT’S GOING ON!Chairmen: J.P. Collet, D. Dudek
16.45 Rationale for Triple therapy in ACS - G. Galasso
16.55 PAR-1 Antagonists - F. Varbella
17.05 Factor Xa Inhibitors - A. Mafrici
17.15 MODERATED DISCUSSIONDiscussants: G. Galasso, G. Musumeci, G. Parodi,
F. Piscione, G.G. Secco
SESSION III FLASH DEBATE: OPTIMAL ANTITHROMBOTIC THERAPY IN STEMI WITH NEW ORAL ADP ANTAGONISTS Chairmen: K. Huber, G. Parodi
17.30 Gp IIb-IIIa inhibitors - G. De Luca
17.40 Bivalirudin - D. Dudek
17.55 Cangrelor: a new player? - A. Rognoni
18.05 MODERATED DISCUSSIONDiscussants: A. Lupi, M. Romano, G. Tarantini,
F. Varbella, U. Zeymer
SESSION IV YOUNG INTERVENTIONALIST COMPETITION: MY WORST COMPLICATION IN THE CATH LAB! Chairmen: D. Antonucci, D. DudekDiscussants: G. Belli, M. D’Amico, P. Gaetano,
M. Romano, P. Silva, H. Thiele
19.20 LECTURENew ADP antagonists and Gp IIb-IIIa inhibitors in ACS: when and how to use - J.P. Collet
DAY 1 - FRIDAY, OCTOBER 10, 2014
SESSION V ANTIPLATELET THERAPY AND SURGERY Chairmen: P. Marino, L. Oltrona-Visconti
08.30 Need of surgery under dual antiplatelet therapy:Prevalence and Outcome - S. De Servi
08.40 Current status on Bridge therapy - S. Savonitto
08.50 The Italian consensus document - G. Musumeci
09.00 SAS Registry - R. Rossini
09.10 MODERATED DISCUSSIONDiscussants: M. Commodo, M. D’Urbano, F. Grassi,
E. Passamonti, A. Rognoni, C. Sponzilli,
SESSION VIFLASH DEBATE: THROMBECTOMY IN 2014 Chairmen: K. Huber, H. Suryapranata
09.25 No proof for routine thrombectomy - S. James
09.35 No power no party: go for rheolytic thrombectomy - D. Antoniucci
09.45 MODERATED DISCUSSIONDiscussants: R. Garbo, E. Kedhi, E. Meliga,
R. Moreno, G.G. Secco, A. Silvestro
SESSION VIIANTITHROMBOTIC MANAGEMENT OF ACS PATIENTS WITH ATRIAL FIBRILLATION Chairmen: S. James, R. Moreno
10.00 Prevalence and management of AF in ACS - F. Saia
10.10 Triple therapy: The WOEST study - E. Kedhi
10.20 New Oral Anticoagulants and new ADP-antagonists: how do they fit? - K. Huber
10.30 New stent strategies - E. Meliga
10.40 MODERATED DISCUSSIONDiscussants: G. Boccuzzi, D. Capodanno,
P. Colombo, M. Ferlini, P. Gaetano, H. Thiele
11.00 Coffee break
SESSION VIII TAVI: THE NEW HORIZONS Chairmen: S. Berti, G. Pedrazzini
11.30 Balloon expandable valves: what’s new - G. Napodano
11.40 TAVI for aortic regurgitation: current data and future indications - L. Testa
11.50 New valves - F. De Marco
12.00 DISCUSSIONDiscussants: G. Bruschi, P. Colombo,
M. Commodo, C. Moretti,M. Napodano, F. Saia, M. Tespili
DAY 2 - SATURDAY, OCTOBER 11, 2014
SESSION IX YOUNG INTERVENTIONALIST COMPETITION: MY WORST COMPLICATION IN THE CATH LAB! Chairmen: R. Garbo, M. Tespili
13.00 LECTUREMechanical support for cardiogenic shock: from the present to the future - H. Thiele
13.30 Lunch
POSTER SESSION
SESSION X BEYOND THROMBOSIS AND REVASCULARIZATION.NEW DRUGS IN THE ARENA Chairmen: G. De Luca, G. Parodi
14.30 Ranolazine: rationale, current data and ongoing trials - F. Pelliccia
14.40 HDL and CETP inhibitors - L. Calabresi
14.50 Erectile dysfunction: prevalence, prognostic implications and therapeutic approach - F. Lanfranco
15.00 MODERATED DISCUSSIONDiscussants: G. Galasso, A. Lupi, G.G. Secco
SESSION XI DES IN ACS: 2014 UPDATE Chairmen: A.S. Bongo, D. Antoniucci
15.20 Dual-therapy stent - H. Suryapranata
15.30 Self-expanding stent - D. Capodanno
15.40 Bioabsorbable polymer with everolimus - R. Moreno
15.50 Hybrid DES - G.G. Secco
16.00 CoCr SES with hydrophilic coating and Bioabsorbable polymer - G.B. Danzi
16.10 Polymer-free SES and stainless steel SES with Bioabsorbable polymer - G. De Luca
16.20 BVS: when and how - G. Boccuzzi
16.30 IVUS for optimal stenting: routine or selective use? - A. Lupi
16.40 MODERATED DISCUSSIONDiscussants: L. Golino, E. Piccaluga,
A. Rognoni, G. Tarantini
17.00 LECTUREmiRNAs and cardiovascular disease: state-of-the-art - L. EliaPresenter: G. De Luca
17.30 CEREMONYWinners of Young Investigator competitions
18.00 Conclusions
DAY 2 - SATURDAY, OCTOBER 11, 2014
J.P. Collet Paris, France
D. Dudek Krakow, Poland
K. Huber Vienna, Austria
S. James Upssala, Sweden
E. Kedhi Zwolle, The Netherlands
R. Moreno Madrid, Spain
M. Noc Ljiubiana, Slovenia
G. Pedrazzini Lugano, Switzerland
H. Suryapranata Nijmegen, The Netherlands
H. Thiele Leipzig, Germany
A.W.J. van’t Hof Zwolle, The Netherlands
U. Zeymer Ludwigshafen, Germany
F. Airoldi Milan
D. Antoniucci Florence
D. Ardissino Parma
G. Belli Bergamo
S. Berti Massa
G. Boccuzzi Turin
L. Bolognese Arezzo
A.S. Bongo Novara
G. Bruschi Milan
L. Calabresi Milan
D. Capodanno Catania
M. Carlino Milan
M. Cattaneo Milan
P. Colombo Milan
M. Commodo Novara
G.B. Danzi Milan
M. D’Amico Torino
M. De Benedictis Turin
G. De Luca Novara
F. De Marco Milan
S. De Servi Pavia
M. D’Urbano Magenta
L. Elia Milan
M. Ferlini Pavia
P. Gaetano Ciriè
G. Galasso Naples
R. Garbo Turin
C. Godino Milan
L. Golino Gravedona
F. Grassi Novara
F. Lanfranco Turin
C. Lettieri Mantova
A. Lupi Novara
A. Mafrici Milan
P. Marino Novara
E. Meliga Turin
C. Moretti Turin
G. Musumeci Bergamo
M. Napodano Padua
L. Oltrona-Visconti Pavi
G. Parodi Florence
E. Passamonti Cremona
F. Pelliccia Rome
E. Piccaluga Milan
F. Piscione Salerno
P. Presbitero Milan
A. Rognoni Novara
M. Romano Mantova
R. Rossini Bergamo
F. Saia Bologna
S. Savonitto Lecco
G.G. Secco Novara
P. Silva Milan
A. Silvestro Seriate
C. Sponzilli Milano
G. Tarantini Padua
M. Tespili Seriate
L. Testa Milan
F. Varbella Turin
INTERNATIONAL FACULTY NATIONAL FACULTY
COURSE DIRECTORSGiuseppe De Luca (Italy)Harry Suryapranata (The Netherlands)
SCIENTIFIC COMMITTEE Giuseppe De Luca (Italy)Harry Suryapranata (The Netherlands)David Antoniucci (Italy)Dariusz Dudek (Poland)Guido Parodi (Italy)
SCIENTIFIC SECRETARYMonica VerdoiaAlon SchafferEttore CassettiLucia BarbieriGabriella Di Giovine Matteo Nardin
CONGRESS VENUEGrand Hotel DinoCorso Garibaldi, 20 • 28831 Baveno • Italy
C.M.E. PROVIDER
Via Roma, 10 • 16121 Genova • ItalyTel. (+39) 010 553591 • Fax (+39) 010 5535970E-mail [email protected] • Web www.aristea.com
C.M.E. Only for Italian ParticipantsIl Congresso è stato inserito da Aristea Education - Provideraccreditato dalla Commissione Nazionale per FormazioneContinua con il numero di accreditamento 500 - nel propriopiano formativo 2014 nell’ambito del Programma NazionaleE.C.M. (Educazione Continua in Medicina). Il Congresso è destinato alle seguenti figure professionali:
Tecnico Sanitario di Radiologia Medica, Medico Chirurgo(Discipline: Cardiologia, Ematologia, Geriatria, MalattieMetaboliche e Diabetologia, Medicina e Chirurgia di Accet-tazione e d’Urgenza, Medicina Interna, Nefrologia, Psichiatria,Cardiochirurgia, Chirurgia Generale, Chirurgia Toracica,Chirurgia Vascolare, Anestesia e Rianimazione, MedicinaGenerale (Medici di Famiglia), Infermiere e riconosce n. 12crediti formativi per 80 partecipanti. L’attestazione dei crediti è subordinata alla partecipazioneeffettiva all’intero programma formativo, nella misura del100%, ed alla verifica dell’apprendimento. L’attestato di partecipazione, riportante il numero di creditiassegnati, verrà pertanto rilasciato dopo avere effettuatotali verifiche e sarà quindi disponibile on-line sul sito webwww.aristea.com 60 giorni dopo la chiusura dell’evento. Per ogni ulteriore informazione si rimanda all’indirizzo webwww.aristea.com/ecm
OBIETTIVO FORMATIVOLinee Guida - Protocolli - Procedure.
ON-LINE REGISTRATIONThe registration is free of charge but mandatory. For on-lineregistration please visit the website of the Congress:www.aristea.com/acscrossroads
ORGANIZING SECRETARIAT
Via Roma, 10 • 16121 Genova • ItalyTel. (+39) 010 553591 • Fax (+39) 010 5535970E-mail [email protected] • Web www.aristea.com
WEB SITEwww.aristea.com/acscrossroads
GENERAL INFORMATION